Jennison Associates LLC Invests $645,000 in Cellebrite DI Ltd. (NASDAQ:CLBT)

Jennison Associates LLC acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 33,184 shares of the company's stock, valued at approximately $645,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Victory Capital Management Inc. acquired a new position in shares of Cellebrite DI in the 4th quarter valued at $234,000. HighTower Advisors LLC acquired a new position in shares of Cellebrite DI in the 4th quarter valued at $274,000. Swiss National Bank lifted its stake in shares of Cellebrite DI by 24.5% in the 4th quarter. Swiss National Bank now owns 150,600 shares of the company's stock valued at $3,318,000 after purchasing an additional 29,600 shares during the last quarter. Teacher Retirement System of Texas acquired a new position in shares of Cellebrite DI in the 4th quarter valued at $442,000. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in shares of Cellebrite DI by 9.7% in the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 190,012 shares of the company's stock valued at $4,186,000 after purchasing an additional 16,792 shares during the last quarter. Institutional investors and hedge funds own 45.88% of the company's stock.

Cellebrite DI Stock Performance

CLBT stock traded down $0.26 during mid-day trading on Friday, reaching $14.32. The company had a trading volume of 1,071,768 shares, compared to its average volume of 1,550,164. The company has a market capitalization of $3.43 billion, a price-to-earnings ratio of -14.92, a price-to-earnings-growth ratio of 2.94 and a beta of 1.28. The firm has a fifty day simple moving average of $15.80 and a 200 day simple moving average of $18.72. Cellebrite DI Ltd. has a fifty-two week low of $11.90 and a fifty-two week high of $26.30.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last posted its quarterly earnings results on Wednesday, May 14th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.01. The company had revenue of $107.55 million for the quarter, compared to analyst estimates of $109.36 million. Cellebrite DI had a positive return on equity of 35.36% and a negative net margin of 46.34%. Cellebrite DI's revenue for the quarter was up 20.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.08 EPS. As a group, analysts predict that Cellebrite DI Ltd. will post 0.3 earnings per share for the current year.

Wall Street Analysts Forecast Growth

CLBT has been the topic of several recent analyst reports. Needham & Company LLC reaffirmed a "buy" rating and issued a $24.00 price target on shares of Cellebrite DI in a research note on Friday, June 6th. JPMorgan Chase & Co. decreased their target price on Cellebrite DI from $29.00 to $25.00 and set an "overweight" rating on the stock in a research note on Monday, May 12th. Seven analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Cellebrite DI has an average rating of "Buy" and an average price target of $22.43.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.